Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone-sensitive prostate cancer.
Naito Y, Kato M, Kawanishi H, Yamamoto A, Sakamoto F, Hirabayashi H, Kobayashi M, Matsukawa Y, Kimura T, Araki H, Nishikimi T, Kondo A, Yoshino Y, Hashimoto Y, Nakano Y, Tsuzuki T.
Naito Y, et al. Among authors: nakano y.
Prostate. 2023 Mar;83(4):307-315. doi: 10.1002/pros.24462. Epub 2022 Nov 24.
Prostate. 2023.
PMID: 36420892